{
    "abstract": "Smallpox is a disease caused by Variola virus (VARV). Although eradicated by WHO in 1980, the threat of using VARV on a bioterror attack has increased. The current smallpox vaccine ACAM2000, which consists of live vaccinia virus (VACV), causes complications in individuals with a compromised immune system or with previously reported skin diseases. Thus, a safer and efficacious vaccine needs to be developed. Previously, we reported that our virus-free DNA vaccine formulation, a pVAX1 plasmid encoding codon-optimized VACV A27L gene (pA27LOPT) with and without Imiquimod adjuvant, stimulates A27L-specific production of IFN-\u03b3 and increases humoral immunity 7 days post-vaccination. Here, we investigated the immune response of our novel vaccine by measuring the frequency of splenocytes producing IFN-\u03b3 by ELISPOT, the TH1 and TH2 cytokine profiles, and humoral immune responses two weeks post-vaccination, when animals were challenged with VACV. In all assays, the A27-based DNA vaccine conferred protective immune responses. Specifically, two weeks after vaccination, mice were challenged intranasally with vaccinia virus, and viral titers in mouse lungs and ovaries were significantly lower in groups immunized with pA27LOPT and pA27LOPT + Imiquimod. These results demonstrate that our vaccine formulation decreases viral replication and dissemination in a virus-free DNA vaccine platform, and provides an alternative towards a safer an efficacious vaccine.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Derrick",
                    "initial": "D.",
                    "last": "Baxby"
                }
            ],
            "doi": "10.1016/S0264-410X(02)00028-2",
            "firstpage": "2140",
            "issn": "0264410X",
            "lastpage": "2149",
            "pmid": "11972983",
            "pub_year": 2002,
            "title": "Smallpox vaccination techniques; from knives and forks to needles and pins",
            "volume": "20"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Aysegul",
                    "initial": "A.",
                    "last": "Nalca"
                },
                {
                    "first": "Elizabeth E.",
                    "initial": "E.E.",
                    "last": "Zumbrun"
                }
            ],
            "doi": "10.2147/dddt.s3687",
            "firstpage": "71",
            "issn": "11778881",
            "lastpage": "79",
            "pmid": "20531961",
            "pub_year": 2010,
            "title": "ACAM2000\u2122: The new smallpox vaccine for United States Strategic National Stockpile",
            "volume": "4"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Salah S.",
                    "initial": "S.S.",
                    "last": "Qutaishat"
                },
                {
                    "first": "John L.",
                    "initial": "J.L.",
                    "last": "Olson"
                }
            ],
            "doi": "10.3121/cmr.1.2.85",
            "firstpage": "85",
            "issn": "15394182",
            "lastpage": "86",
            "pmid": "15931292",
            "pub_year": 2003,
            "title": "Bioterrorism preparedness: the smallpox vaccine debate.",
            "volume": "1"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Alex R.",
                    "initial": "A.R.",
                    "last": "Kemper"
                },
                {
                    "first": "Matthew M.",
                    "initial": "M.M.",
                    "last": "Davis"
                },
                {
                    "first": "Gary L.",
                    "initial": "G.L.",
                    "last": "Freed"
                }
            ],
            "firstpage": "84",
            "issn": "10998128",
            "lastpage": "90",
            "pmid": "11990216",
            "pub_year": 2002,
            "title": "Expected adverse events in a mass smallpox vaccination campaign.",
            "volume": "5"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Cressida",
                    "initial": "C.",
                    "last": "Auckland"
                },
                {
                    "first": "Alexandra",
                    "initial": "A.",
                    "last": "Cowlishaw"
                },
                {
                    "first": "Dilys",
                    "initial": "D.",
                    "last": "Morgan"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1016/j.vaccine.2004.10.052",
            "firstpage": "4185",
            "issn": "0264410X",
            "lastpage": "4187",
            "pmid": "15916840",
            "pub_year": 2005,
            "title": "Reactions to small pox vaccine in na\u00efve and previously-vaccinated individuals",
            "volume": "23"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Joanne",
                    "initial": "J.",
                    "last": "Cono"
                },
                {
                    "first": "Christine G.",
                    "initial": "C.G.",
                    "last": "Casey"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Bell"
                }
            ],
            "firstpage": "1",
            "issn": "10575987",
            "lastpage": "28",
            "pmid": "12617510",
            "pub_year": 2003,
            "title": "Smallpox vaccination and adverse reactions. Guidance for clinicians.",
            "volume": "52"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Cyril",
                    "initial": "C.",
                    "last": "Empig"
                },
                {
                    "first": "Julie R.",
                    "initial": "J.R.",
                    "last": "Kenner"
                },
                {
                    "first": "Marcel",
                    "initial": "M.",
                    "last": "Perret-Gentil"
                },
                {
                    "first": "Bryan E.",
                    "initial": "B.E.",
                    "last": "Youree"
                },
                {
                    "first": "Edward",
                    "initial": "E.",
                    "last": "Bell"
                },
                {
                    "first": "Allen",
                    "initial": "A.",
                    "last": "Chen"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Gurwith"
                },
                {
                    "first": "Keith",
                    "initial": "K.",
                    "last": "Higgins"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Lock"
                },
                {
                    "first": "Amanda D.",
                    "initial": "A.D.",
                    "last": "Rice"
                },
                {
                    "first": "Jill",
                    "initial": "J.",
                    "last": "Schriewer"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "White"
                },
                {
                    "first": "R. Mark",
                    "initial": "R.M.",
                    "last": "Buller"
                },
                {
                    "first": "Terence S.",
                    "initial": "T.S.",
                    "last": "Dermody"
                },
                {
                    "first": "Stuart N.",
                    "initial": "S.N.",
                    "last": "Isaacs"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Moyer"
                }
            ],
            "doi": "10.1016/j.vaccine.2005.03.029",
            "firstpage": "3686",
            "issn": "0264410X",
            "lastpage": "3694",
            "pmid": "16430997",
            "pub_year": 2006,
            "title": "Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge",
            "volume": "24"
        },
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "Jong J.",
                    "initial": "J.J.",
                    "last": "Kim"
                },
                {
                    "first": "Velpandi",
                    "initial": "V.",
                    "last": "Ayyavoo"
                },
                {
                    "first": "Mark L.",
                    "initial": "M.L.",
                    "last": "Bagarazzi"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Chattergoon"
                },
                {
                    "first": "Jean D.",
                    "initial": "J.D.",
                    "last": "Boyer"
                },
                {
                    "first": "Bin",
                    "initial": "B.",
                    "last": "Wang"
                },
                {
                    "first": "David B.",
                    "initial": "D.B.",
                    "last": "Weiner"
                }
            ],
            "doi": "10.1016/S0264-410X(96)00260-5",
            "firstpage": "879",
            "issn": "0264410X",
            "lastpage": "883",
            "pmid": "9234538",
            "pub_year": 1997,
            "title": "Development of a multicompanent candidate vaccine for HIV-1",
            "volume": "15"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Yvette",
                    "initial": "Y.",
                    "last": "Edghill-Smitli"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Bray"
                },
                {
                    "first": "Chris A.",
                    "initial": "C.A.",
                    "last": "Whitehouse"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Miller"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Mucker"
                },
                {
                    "first": "Jody",
                    "initial": "J.",
                    "last": "Manischewitz"
                },
                {
                    "first": "Lisa R.",
                    "initial": "L.R.",
                    "last": "King"
                },
                {
                    "first": "Marjorie",
                    "initial": "M.",
                    "last": "Hobart-Guroff"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Hryniewicz"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Venzom"
                },
                {
                    "first": "Clement",
                    "initial": "C.",
                    "last": "Meseda"
                },
                {
                    "first": "Jerry",
                    "initial": "J.",
                    "last": "Weir"
                },
                {
                    "first": "Aysegul",
                    "initial": "A.",
                    "last": "Nalca"
                },
                {
                    "first": "Virginia",
                    "initial": "V.",
                    "last": "Livingston"
                },
                {
                    "first": "Jay",
                    "initial": "J.",
                    "last": "Wells"
                },
                {
                    "first": "Mark G.",
                    "initial": "M.G.",
                    "last": "Lewis"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Muggins"
                },
                {
                    "first": "Susan H.",
                    "initial": "S.H.",
                    "last": "Zwiers"
                },
                {
                    "first": "Hana",
                    "initial": "H.",
                    "last": "Golding"
                },
                {
                    "first": "Genoveffa",
                    "initial": "G.",
                    "last": "Franchini"
                }
            ],
            "doi": "10.1086/427265",
            "firstpage": "372",
            "issn": "00221899",
            "lastpage": "381",
            "pmid": "15633096",
            "pub_year": 2005,
            "title": "Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge",
            "volume": "191"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Lesia K.",
                    "initial": "L.K.",
                    "last": "Dropulic"
                },
                {
                    "first": "Robert H.",
                    "initial": "R.H.",
                    "last": "Rubin"
                },
                {
                    "first": "John G.",
                    "initial": "J.G.",
                    "last": "Bartlett"
                }
            ],
            "doi": "10.1086/374716",
            "firstpage": "786",
            "issn": "10584838",
            "lastpage": "788",
            "pmid": "12627364",
            "pub_year": 2003,
            "title": "Smallpox vaccination and the patient with an organ transplant",
            "volume": "36"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Jay A.",
                    "initial": "J.A.",
                    "last": "Fishman"
                }
            ],
            "doi": "10.1034/j.1600-6143.2003.00145.x",
            "firstpage": "786",
            "issn": "16006135",
            "lastpage": "793",
            "pmid": "12814470",
            "pub_year": 2003,
            "title": "Smallpox and live-virus vaccination in transplant recipients",
            "volume": "3"
        },
        "b0065": {
            "authors": [
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Donnelly"
                },
                {
                    "first": "Jeffrey B.",
                    "initial": "J.B.",
                    "last": "Ulmer"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Shiver"
                },
                {
                    "first": "Margaret A.",
                    "initial": "M.A.",
                    "last": "Liu"
                }
            ],
            "doi": "10.1146/annurev.immunol.15.1.617",
            "firstpage": "617",
            "issn": "07320582",
            "lastpage": "648",
            "pmid": "9143702",
            "pub_year": 1997,
            "title": "DNA vaccines",
            "volume": "15"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Adam D.",
                    "initial": "A.D.",
                    "last": "Cohen"
                },
                {
                    "first": "Jean D.",
                    "initial": "J.D.",
                    "last": "Boyer"
                },
                {
                    "first": "David B.",
                    "initial": "D.B.",
                    "last": "Weiner"
                }
            ],
            "doi": "10.1096/fasebj.12.15.1611",
            "firstpage": "1611",
            "issn": "08926638",
            "lastpage": "1626",
            "pmid": "9837851",
            "pub_year": 1998,
            "title": "Modulating the immune response to genetic immunization",
            "volume": "12"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Reinhold",
                    "initial": "R.",
                    "last": "Schirmbeck"
                },
                {
                    "first": "J\u00f6rg",
                    "initial": "J.",
                    "last": "Reimann"
                }
            ],
            "doi": "10.1515/BC.2001.068",
            "firstpage": "543",
            "issn": "14316730",
            "lastpage": "552",
            "pmid": "11405219",
            "pub_year": 2001,
            "title": "Revealing the potential of DNA-based vaccination: Lessons learned from the hepatitis B virus surface antigen",
            "volume": "382"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Douglas G.",
                    "initial": "D.G.",
                    "last": "McNeel"
                },
                {
                    "first": "Jordan T.",
                    "initial": "J.T.",
                    "last": "Becker"
                },
                {
                    "first": "Laura E.",
                    "initial": "L.E.",
                    "last": "Johnson"
                },
                {
                    "first": "Brian M.",
                    "initial": "B.M.",
                    "last": "Olson"
                }
            ],
            "firstpage": "245",
            "issn": "15733947",
            "lastpage": "253",
            "pub_year": 2012,
            "title": "DNA vaccines for prostate cancer",
            "volume": "8"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Julie E.",
                    "initial": "J.E.",
                    "last": "Martin"
                },
                {
                    "first": "Nancy J.",
                    "initial": "N.J.",
                    "last": "Sullivan"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Enama"
                },
                {
                    "first": "Ingelise J.",
                    "initial": "I.J.",
                    "last": "Gordon"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Roederer"
                },
                {
                    "first": "Richard A.",
                    "initial": "R.A.",
                    "last": "Koup"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Bailer"
                },
                {
                    "first": "Bimal K.",
                    "initial": "B.K.",
                    "last": "Chakrabarti"
                },
                {
                    "first": "Michael A.",
                    "initial": "M.A.",
                    "last": "Bailey"
                },
                {
                    "first": "Phillip L.",
                    "initial": "P.L.",
                    "last": "Gomez"
                },
                {
                    "first": "Charla A.",
                    "initial": "C.A.",
                    "last": "Andrews"
                },
                {
                    "first": "Zoe",
                    "initial": "Z.",
                    "last": "Moodie"
                },
                {
                    "first": "Lin",
                    "initial": "L.",
                    "last": "Gu"
                },
                {
                    "first": "Judith A.",
                    "initial": "J.A.",
                    "last": "Stein"
                },
                {
                    "first": "Gary J.",
                    "initial": "G.J.",
                    "last": "Nabel"
                },
                {
                    "first": "Barney S.",
                    "initial": "B.S.",
                    "last": "Graham"
                },
                {
                    "first": "Margaret M.",
                    "initial": "M.M.",
                    "last": "McCluskey"
                },
                {
                    "first": "Brenda",
                    "initial": "B.",
                    "last": "Larkin"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Hubka"
                },
                {
                    "first": "Lasonji",
                    "initial": "L.",
                    "last": "Holman"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Novik"
                },
                {
                    "first": "Pamela",
                    "initial": "P.",
                    "last": "Edmonds"
                },
                {
                    "first": "Steve",
                    "initial": "S.",
                    "last": "Rucker"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Scott"
                },
                {
                    "first": "Colleen",
                    "initial": "C.",
                    "last": "Thomas"
                },
                {
                    "first": "La Chonne",
                    "initial": "L.C.",
                    "last": "Stanford"
                },
                {
                    "first": "Ed",
                    "initial": "E.",
                    "last": "Tramont"
                },
                {
                    "first": "Woody",
                    "initial": "W.",
                    "last": "Dubois"
                },
                {
                    "first": "Tiffany",
                    "initial": "T.",
                    "last": "Alley"
                },
                {
                    "first": "Erica",
                    "initial": "E.",
                    "last": "Eaton"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Sitar"
                },
                {
                    "first": "Ericka",
                    "initial": "E.",
                    "last": "Thompson"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Catanzaro"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Casazza"
                },
                {
                    "first": "Janie",
                    "initial": "J.",
                    "last": "Parrino"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Lemiale"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Sheets"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Turk"
                },
                {
                    "first": "Laurie",
                    "initial": "L.",
                    "last": "Lamoreaux"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Fischer"
                },
                {
                    "first": "Mara",
                    "initial": "M.",
                    "last": "Abashian"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Rathmann"
                },
                {
                    "first": "Adrienne",
                    "initial": "A.",
                    "last": "McNeil"
                }
            ],
            "doi": "10.1128/CVI.00162-06",
            "firstpage": "1267",
            "issn": "15566811",
            "lastpage": "1277",
            "pmid": "16988008",
            "pub_year": 2006,
            "title": "A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial",
            "volume": "13"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Margaret A.",
                    "initial": "M.A.",
                    "last": "Liu"
                },
                {
                    "first": "Jeffrey B.",
                    "initial": "J.B.",
                    "last": "Ulmer"
                }
            ],
            "doi": "10.1016/S0065-2660(05)55002-8",
            "firstpage": "25",
            "issn": "00652660",
            "lastpage": "40",
            "pmid": "16291211",
            "pub_year": 2005,
            "title": "Human Clinical Trials of Plasmid DNA Vaccines",
            "volume": "55"
        },
        "b0095": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Reimann"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Schirmbeck"
                }
            ],
            "firstpage": "57",
            "issn": "00429007",
            "lastpage": "60",
            "pmid": "10938928",
            "pub_year": 2000,
            "title": "DNA vaccines.",
            "volume": "78"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Calarota"
                },
                {
                    "first": "G\u00f6ran",
                    "initial": "G.",
                    "last": "Bratt"
                },
                {
                    "first": "Siv",
                    "initial": "S.",
                    "last": "Nordlund"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Hinkula"
                },
                {
                    "first": "Ann Charlotte",
                    "initial": "A.C.",
                    "last": "Leandersson"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Sandstr\u00f6m"
                },
                {
                    "first": "Britta",
                    "initial": "B.",
                    "last": "Wahren"
                }
            ],
            "doi": "10.1016/S0140-6736(97)09440-3",
            "firstpage": "1320",
            "issn": "01406736",
            "lastpage": "1325",
            "pmid": "9643795",
            "pub_year": 1998,
            "title": "Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients",
            "volume": "351"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Sandra A.",
                    "initial": "S.A.",
                    "last": "Calarota"
                },
                {
                    "first": "Ann Charlotte",
                    "initial": "A.C.",
                    "last": "Leandersson"
                },
                {
                    "first": "G\u00f6ran",
                    "initial": "G.",
                    "last": "Bratt"
                },
                {
                    "first": "Jorma",
                    "initial": "J.",
                    "last": "Hinkula"
                },
                {
                    "first": "Dennis M.",
                    "initial": "D.M.",
                    "last": "Klinman"
                },
                {
                    "first": "Kent J.",
                    "initial": "K.J.",
                    "last": "Weinhold"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Sandstr\u00f6m"
                },
                {
                    "first": "Britta",
                    "initial": "B.",
                    "last": "Wahren"
                }
            ],
            "firstpage": "2330",
            "issn": "00221767",
            "lastpage": "2338",
            "pmid": "10438897",
            "pub_year": 1999,
            "title": "Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment",
            "volume": "163"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Rob Roy",
                    "initial": "R.R.",
                    "last": "MacGregor"
                },
                {
                    "first": "Jean D.",
                    "initial": "J.D.",
                    "last": "Boyer"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Ugen"
                },
                {
                    "first": "Kim E.",
                    "initial": "K.E.",
                    "last": "Lacy"
                },
                {
                    "first": "Stephen J.",
                    "initial": "S.J.",
                    "last": "Gluckman"
                },
                {
                    "first": "Mark L.",
                    "initial": "M.L.",
                    "last": "Bagarazzi"
                },
                {
                    "first": "Michael A.",
                    "initial": "M.A.",
                    "last": "Chattergoon"
                },
                {
                    "first": "Yaela",
                    "initial": "Y.",
                    "last": "Baine"
                },
                {
                    "first": "Terry J.",
                    "initial": "T.J.",
                    "last": "Higgins"
                },
                {
                    "first": "Richard B.",
                    "initial": "R.B.",
                    "last": "Ciccarelli"
                },
                {
                    "first": "Leslie R.",
                    "initial": "L.R.",
                    "last": "Coney"
                },
                {
                    "first": "Richard S.",
                    "initial": "R.S.",
                    "last": "Ginsberg"
                },
                {
                    "first": "David B.",
                    "initial": "D.B.",
                    "last": "Weiner"
                }
            ],
            "doi": "10.1086/515613",
            "firstpage": "92",
            "issn": "00221899",
            "lastpage": "100",
            "pmid": "9652427",
            "pub_year": 1998,
            "title": "First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response",
            "volume": "178"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Osmarie",
                    "initial": "O.",
                    "last": "Mart\u00ednez"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Miranda"
                },
                {
                    "first": "Maite",
                    "initial": "M.",
                    "last": "Ram\u00edrez"
                },
                {
                    "first": "Saritza",
                    "initial": "S.",
                    "last": "Santos"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Rivera"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "V\u00e1zquez"
                },
                {
                    "first": "Tom\u00e1s",
                    "initial": "T.",
                    "last": "S\u00e1nchez"
                },
                {
                    "first": "Raymond L.",
                    "initial": "R.L.",
                    "last": "Tremblay"
                },
                {
                    "first": "Eddy",
                    "initial": "E.",
                    "last": "R\u00edos-Olivares"
                },
                {
                    "first": "Miguel",
                    "initial": "M.",
                    "last": "Otero"
                }
            ],
            "doi": "10.1371/journal.pone.0123113",
            "issn": "19326203",
            "pmid": "25875833",
            "pub_year": 2015,
            "title": "Immunomodulator-based enhancement of anti smallpox immune responses",
            "volume": "10"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Hyun Jeong",
                    "initial": "H.J.",
                    "last": "Ko"
                },
                {
                    "first": "Sung Youl",
                    "initial": "S.Y.",
                    "last": "Ko"
                },
                {
                    "first": "Yeon Jeong",
                    "initial": "Y.J.",
                    "last": "Kim"
                },
                {
                    "first": "Eun Gae",
                    "initial": "E.G.",
                    "last": "Lee"
                },
                {
                    "first": "Sang Nae",
                    "initial": "S.N.",
                    "last": "Cho"
                },
                {
                    "first": "Chang Yuil",
                    "initial": "C.Y.",
                    "last": "Kang"
                }
            ],
            "doi": "10.1128/IAI.73.9.5666-5674.2005",
            "firstpage": "5666",
            "issn": "00199567",
            "lastpage": "5674",
            "pmid": "16113284",
            "pub_year": 2005,
            "title": "Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B",
            "volume": "73"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Feng",
                    "initial": "F.",
                    "last": "Gao"
                },
                {
                    "first": "Yingying",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Julie M.",
                    "initial": "J.M.",
                    "last": "Decker"
                },
                {
                    "first": "Fred W.",
                    "initial": "F.W.",
                    "last": "Peyerl"
                },
                {
                    "first": "Frederic",
                    "initial": "F.",
                    "last": "Bibollet-Ruche"
                },
                {
                    "first": "Cynthia M.",
                    "initial": "C.M.",
                    "last": "Rodenburg"
                },
                {
                    "first": "Yalu",
                    "initial": "Y.",
                    "last": "Chen"
                },
                {
                    "first": "Denise R.",
                    "initial": "D.R.",
                    "last": "Shaw"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Allen"
                },
                {
                    "first": "Rosemary",
                    "initial": "R.",
                    "last": "Musonda"
                },
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Shaw"
                },
                {
                    "first": "Allan J.",
                    "initial": "A.J.",
                    "last": "Zajac"
                },
                {
                    "first": "Norman",
                    "initial": "N.",
                    "last": "Letvin"
                },
                {
                    "first": "Beatrice H.",
                    "initial": "B.H.",
                    "last": "Hahn"
                }
            ],
            "doi": "10.1089/088922203769232610",
            "firstpage": "817",
            "issn": "08892229",
            "lastpage": "823",
            "pmid": "14585212",
            "pub_year": 2003,
            "title": "Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: In vitro expression and immune responses in DNA-vaccinated mice",
            "volume": "19"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Rong",
                    "initial": "R.",
                    "last": "Xu"
                },
                {
                    "first": "Aaron J.",
                    "initial": "A.J.",
                    "last": "Johnson"
                },
                {
                    "first": "Denny",
                    "initial": "D.",
                    "last": "Liggitt"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Bevan"
                }
            ],
            "doi": "10.4049/jimmunol.172.10.6265",
            "firstpage": "6265",
            "issn": "00221767",
            "lastpage": "6271",
            "pmid": "15128815",
            "pub_year": 2004,
            "title": "Cellular and Humoral Immunity against Vaccinia Virus Infection of Mice",
            "volume": "172"
        },
        "b0135": null,
        "b0140": {
            "authors": [
                {
                    "first": "Mark K.",
                    "initial": "M.K.",
                    "last": "Slifka"
                },
                {
                    "first": "J. Lindsay",
                    "initial": "J.L.",
                    "last": "Whitton"
                }
            ],
            "doi": "10.4049/jimmunol.164.1.208",
            "firstpage": "208",
            "issn": "00221767",
            "lastpage": "216",
            "pmid": "10605013",
            "pub_year": 2000,
            "title": "Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers",
            "volume": "164"
        },
        "b0145": {
            "authors": [
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Rodriguez"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Janeczko"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Esteban"
                }
            ],
            "firstpage": "482",
            "issn": "0022538X",
            "lastpage": "488",
            "pmid": "4057358",
            "pub_year": 1985,
            "title": "Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus",
            "volume": "56"
        },
        "b0150": {
            "authors": [
                {
                    "first": "W. E.",
                    "initial": "W.E.",
                    "last": "Demkowicz"
                },
                {
                    "first": "J. S.",
                    "initial": "J.S.",
                    "last": "Maa"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Esteban"
                }
            ],
            "firstpage": "386",
            "issn": "0022538X",
            "lastpage": "398",
            "pmid": "1727494",
            "pub_year": 1992,
            "title": "Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans",
            "volume": "66"
        },
        "b0155": {
            "authors": [
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Hooper"
                },
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Custer"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Thompson"
                }
            ],
            "doi": "10.1016/S0042-6822(02)00038-7",
            "firstpage": "181",
            "issn": "00426822",
            "lastpage": "195",
            "pmid": "12620810",
            "pub_year": 2003,
            "title": "Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates",
            "volume": "306"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Rajeev",
                    "initial": "R.",
                    "last": "Rudraraju"
                },
                {
                    "first": "Alistair J.",
                    "initial": "A.J.",
                    "last": "Ramsay"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.05.023",
            "firstpage": "4997",
            "issn": "0264410X",
            "lastpage": "5004",
            "pmid": "20653083",
            "pub_year": 2010,
            "title": "Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection",
            "volume": "28"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Gila",
                    "initial": "G.",
                    "last": "Lithwick"
                },
                {
                    "first": "Hanah",
                    "initial": "H.",
                    "last": "Margalit"
                }
            ],
            "doi": "10.1101/gr.1485203",
            "firstpage": "2665",
            "issn": "10889051",
            "lastpage": "2673",
            "pmid": "14656971",
            "pub_year": 2003,
            "title": "Hierarchy of sequence-dependent features associated with prokaryotic translation",
            "volume": "13"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Welch"
                },
                {
                    "first": "Sridhar",
                    "initial": "S.",
                    "last": "Govindarajan"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Ness"
                },
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Villalobos"
                },
                {
                    "first": "Austin",
                    "initial": "A.",
                    "last": "Gurney"
                },
                {
                    "first": "Jeremy",
                    "initial": "J.",
                    "last": "Minshull"
                },
                {
                    "first": "Claes",
                    "initial": "C.",
                    "last": "Gustafsson"
                }
            ],
            "doi": "10.1371/journal.pone.0007002",
            "issn": "19326203",
            "pmid": "19759823",
            "pub_year": 2009,
            "title": "Design parameters to control synthetic gene expression in Eschorichia coli",
            "volume": "4"
        },
        "b0175": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Raab"
                },
                {
                    "first": "Marcus",
                    "initial": "M.",
                    "last": "Graf"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Notka"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Sch\u00f6dl"
                },
                {
                    "first": "Ralf",
                    "initial": "R.",
                    "last": "Wagner"
                }
            ],
            "doi": "10.1007/s11693-010-9062-3",
            "firstpage": "215",
            "issn": "18725325",
            "lastpage": "225",
            "pub_year": 2010,
            "title": "The GeneOptimizer Algorithm: Using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization",
            "volume": "4"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Sang Gu",
                    "initial": "S.G.",
                    "last": "Lee"
                },
                {
                    "first": "Dae You",
                    "initial": "D.Y.",
                    "last": "Kim"
                },
                {
                    "first": "Byung Hwa",
                    "initial": "B.H.",
                    "last": "Hyun"
                },
                {
                    "first": "Yong Soo",
                    "initial": "Y.S.",
                    "last": "Bae"
                }
            ],
            "doi": "10.1128/JVI.76.4.1649-1662.2002",
            "firstpage": "1649",
            "issn": "0022538X",
            "lastpage": "1662",
            "pmid": "11799160",
            "pub_year": 2002,
            "title": "Novel design architecture for genetic stability of recombinant poliovirus: The manipulation of G/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system",
            "volume": "76"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Carton W.",
                    "initial": "C.W.",
                    "last": "Chen"
                },
                {
                    "first": "Jane F.Y.",
                    "initial": "J.F.Y.",
                    "last": "Tsai"
                },
                {
                    "first": "Shuang en",
                    "initial": "S.e.",
                    "last": "Chuang"
                }
            ],
            "doi": "10.1007/BF00329851",
            "firstpage": "154",
            "issn": "00263925",
            "lastpage": "158",
            "pmid": "2823068",
            "pub_year": 1987,
            "title": "Intraplasmid recombination in Streptomyces lividans 66",
            "volume": "209"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Malgorzata",
                    "initial": "M.",
                    "last": "Bzymek"
                },
                {
                    "first": "Susan T.",
                    "initial": "S.T.",
                    "last": "Lovett"
                }
            ],
            "doi": "10.1073/pnas.111008398",
            "firstpage": "8319",
            "issn": "00278424",
            "lastpage": "8325",
            "pmid": "11459970",
            "pub_year": 2001,
            "title": "Instability of repetitive DNA sequences: The role of replication in multiple mechanisms",
            "volume": "98"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Grzegorz",
                    "initial": "G.",
                    "last": "Kudla"
                },
                {
                    "first": "Andrew W.",
                    "initial": "A.W.",
                    "last": "Murray"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Tollervey"
                },
                {
                    "first": "Joshua B.",
                    "initial": "J.B.",
                    "last": "Plotkin"
                }
            ],
            "doi": "10.1126/science.1170160",
            "firstpage": "255",
            "issn": "00368075",
            "lastpage": "258",
            "pmid": "19359587",
            "pub_year": 2009,
            "title": "Coding-sequence determinants of expression in escherichia coli",
            "volume": "324"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Michele A.",
                    "initial": "M.A.",
                    "last": "Kutzler"
                },
                {
                    "first": "David B.",
                    "initial": "D.B.",
                    "last": "Weiner"
                }
            ],
            "doi": "10.1038/nrg2432",
            "firstpage": "776",
            "issn": "14710056",
            "lastpage": "788",
            "pmid": "18781156",
            "pub_year": 2008,
            "title": "DNA vaccines: Ready for prime time?",
            "volume": "9"
        },
        "b0205": null,
        "b0210": {
            "authors": [
                {
                    "first": "A. J.",
                    "initial": "A.J.",
                    "last": "Zajac"
                },
                {
                    "first": "L. E.",
                    "initial": "L.E.",
                    "last": "Harrington"
                }
            ],
            "doi": "10.1016/B978-012374410-4.00799-8",
            "firstpage": "70",
            "lastpage": "77",
            "pub_year": 2008,
            "title": "Immune Response to Viruses: Cell-Mediated Immunity"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Susan L.",
                    "initial": "S.L.",
                    "last": "Swain"
                },
                {
                    "first": "K. Kai",
                    "initial": "K.K.",
                    "last": "McKinstry"
                },
                {
                    "first": "Tara M.",
                    "initial": "T.M.",
                    "last": "Strutt"
                }
            ],
            "doi": "10.1038/nri3152",
            "firstpage": "136",
            "issn": "14741733",
            "lastpage": "148",
            "pmid": "22266691",
            "pub_year": 2012,
            "title": "Expanding roles for CD4 + T cells in immunity to viruses",
            "volume": "12"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Dragana",
                    "initial": "D.",
                    "last": "Jankovic"
                },
                {
                    "first": "Zhugong",
                    "initial": "Z.",
                    "last": "Liu"
                },
                {
                    "first": "William C.",
                    "initial": "W.C.",
                    "last": "Gause"
                }
            ],
            "doi": "10.1016/S1471-4906(01)01975-5",
            "firstpage": "450",
            "issn": "14714906",
            "lastpage": "457",
            "pmid": "11473835",
            "pub_year": 2001,
            "title": "Th1- and Th2-cell commitment during infectious disease: Asymmetry in divergent pathways",
            "volume": "22"
        },
        "b0225": null,
        "b0230": {
            "authors": [
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Tscharke"
                },
                {
                    "first": "Nathan P.",
                    "initial": "N.P.",
                    "last": "Croft"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Doherty"
                },
                {
                    "first": "Nicole L.",
                    "initial": "N.L.",
                    "last": "La Gruta"
                }
            ],
            "doi": "10.1038/nri3905",
            "firstpage": "705",
            "issn": "14741733",
            "lastpage": "716",
            "pmid": "26449178",
            "pub_year": 2015,
            "title": "Sizing up the key determinants of the CD8+ T cell response",
            "volume": "15"
        },
        "b0235": {
            "authors": [
                {
                    "first": "E. John",
                    "initial": "E.J.",
                    "last": "Wherry"
                },
                {
                    "first": "Kristin A.",
                    "initial": "K.A.",
                    "last": "Puorro"
                },
                {
                    "first": "Angel",
                    "initial": "A.",
                    "last": "Porgador"
                },
                {
                    "first": "Laurence C.",
                    "initial": "L.C.",
                    "last": "Eisenlohr"
                }
            ],
            "firstpage": "3735",
            "issn": "00221767",
            "lastpage": "3745",
            "pmid": "10490969",
            "pub_year": 1999,
            "title": "The induction of virus-specific CTL as a function of increasing epitope expression: Responses rise steadily until excessively high levels of epitope are attained",
            "volume": "163"
        },
        "b0240": {
            "authors": [
                {
                    "first": "E. John",
                    "initial": "E.J.",
                    "last": "Wherry"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "McElhaugh"
                },
                {
                    "first": "Laurence C.",
                    "initial": "L.C.",
                    "last": "Eisenlohr"
                }
            ],
            "doi": "10.4049/jimmunol.168.9.4455",
            "firstpage": "4455",
            "issn": "00221767",
            "lastpage": "4461",
            "pmid": "11970989",
            "pub_year": 2002,
            "title": "Generation of CD8+ T cell memory in response to low, high, and excessive levels of epitope",
            "volume": "168"
        },
        "b0245": {
            "authors": [
                {
                    "first": "Pavlo",
                    "initial": "P.",
                    "last": "Sakhatskyy"
                },
                {
                    "first": "Shixia",
                    "initial": "S.",
                    "last": "Wang"
                },
                {
                    "first": "Te hui W.",
                    "initial": "T.h.W.",
                    "last": "Chou"
                },
                {
                    "first": "Shan",
                    "initial": "S.",
                    "last": "Lu"
                }
            ],
            "doi": "10.1016/j.virol.2006.07.017",
            "firstpage": "164",
            "issn": "00426822",
            "lastpage": "174",
            "pmid": "16919703",
            "pub_year": 2006,
            "title": "Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen",
            "volume": "355"
        },
        "b0250": {
            "authors": [
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Hooper"
                },
                {
                    "first": "D. M.",
                    "initial": "D.M.",
                    "last": "Custer"
                },
                {
                    "first": "C. S.",
                    "initial": "C.S.",
                    "last": "Schmaljohn"
                },
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Schmaljohn"
                }
            ],
            "doi": "10.1006/viro.1999.0096",
            "firstpage": "329",
            "issn": "00426822",
            "lastpage": "339",
            "pmid": "10639319",
            "pub_year": 2000,
            "title": "DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge",
            "volume": "266"
        },
        "b0255": {
            "authors": [
                {
                    "first": "Jay W.",
                    "initial": "J.W.",
                    "last": "Hooper"
                },
                {
                    "first": "Joseph W.",
                    "initial": "J.W.",
                    "last": "Golden"
                },
                {
                    "first": "Anthony M.",
                    "initial": "A.M.",
                    "last": "Ferro"
                },
                {
                    "first": "Alan D.",
                    "initial": "A.D.",
                    "last": "King"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.11.017",
            "firstpage": "1814",
            "issn": "0264410X",
            "lastpage": "1823",
            "pmid": "17240007",
            "pub_year": 2007,
            "title": "Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge",
            "volume": "25"
        },
        "b0260": {
            "authors": [
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Pulford"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Gates"
                },
                {
                    "first": "S. H.",
                    "initial": "S.H.",
                    "last": "Bridge"
                },
                {
                    "first": "J. H.",
                    "initial": "J.H.",
                    "last": "Robinson"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Ulaeto"
                }
            ],
            "doi": "10.1016/j.vaccine.2004.02.034",
            "firstpage": "3358",
            "issn": "0264410X",
            "lastpage": "3366",
            "pmid": "15308360",
            "pub_year": 2004,
            "title": "Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge",
            "volume": "22"
        },
        "b0265": {
            "authors": [
                {
                    "first": "Marie C.",
                    "initial": "M.C.",
                    "last": "Galmiche"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Goenaga"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Wittek"
                },
                {
                    "first": "Lorenz",
                    "initial": "L.",
                    "last": "Rindisbacher"
                }
            ],
            "doi": "10.1006/viro.1998.9516",
            "firstpage": "71",
            "issn": "00426822",
            "lastpage": "80",
            "pmid": "9927575",
            "pub_year": 1999,
            "title": "Neutralizing and protective antibodies directed against vaccinia virus envelope antigens",
            "volume": "254"
        },
        "b0270": {
            "authors": [
                {
                    "first": "Charmaine L.",
                    "initial": "C.L.",
                    "last": "Venters"
                },
                {
                    "first": "William J.",
                    "initial": "W.J.",
                    "last": "Graham"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Cassidy"
                },
                {
                    "first": "Sean",
                    "initial": "S.",
                    "last": "Denham"
                }
            ],
            "doi": "10.1586/14760584.3.2.119",
            "firstpage": "119",
            "issn": "14760584",
            "lastpage": "129",
            "pmid": "15056038",
            "pub_year": 2004,
            "title": "Recombinant-HB: Perspectives past, present and future",
            "volume": "3"
        },
        "b0275": {
            "authors": [
                {
                    "first": "Gillian M.",
                    "initial": "G.M.",
                    "last": "Keating"
                },
                {
                    "first": "Stuart",
                    "initial": "S.",
                    "last": "Noble"
                },
                {
                    "first": "F. M.",
                    "initial": "F.M.",
                    "last": "Averhoff"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Belloni"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Duval"
                },
                {
                    "first": "P. N.",
                    "initial": "P.N.",
                    "last": "Goldwater"
                },
                {
                    "first": "A. J.",
                    "initial": "A.J.",
                    "last": "Hall"
                },
                {
                    "first": "M. C.",
                    "initial": "M.C.",
                    "last": "Honorati"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Kallinowski"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Poovorawan"
                }
            ],
            "doi": "10.2165/00003495-200363100-00006",
            "firstpage": "1021",
            "issn": "00126667",
            "lastpage": "1051",
            "pmid": "12699402",
            "pub_year": 2003,
            "title": "Recombinant hepatitis B vaccine (Engerix-B\u00ae): A review of its immunogenicity and protective efficacy against hepatitis B",
            "volume": "63"
        },
        "b0280": {
            "authors": [
                {
                    "first": "Paulo S.",
                    "initial": "P.S.",
                    "last": "Naud"
                },
                {
                    "first": "Cecilia M.",
                    "initial": "C.M.",
                    "last": "Roteli-Martins"
                },
                {
                    "first": "Newton S.",
                    "initial": "N.S.",
                    "last": "De Carvalho"
                },
                {
                    "first": "Julio C.",
                    "initial": "J.C.",
                    "last": "Teixeira"
                },
                {
                    "first": "Paola C.",
                    "initial": "P.C.",
                    "last": "De Borba"
                },
                {
                    "first": "Nervo",
                    "initial": "N.",
                    "last": "Sanchez"
                },
                {
                    "first": "Toufik",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Catteau"
                },
                {
                    "first": "Brecht",
                    "initial": "B.",
                    "last": "Geeraerts"
                },
                {
                    "first": "Dominique",
                    "initial": "D.",
                    "last": "Descamps"
                }
            ],
            "doi": "10.4161/hv.29532",
            "firstpage": "2147",
            "issn": "21645515",
            "lastpage": "2162",
            "pmid": "25424918",
            "pub_year": 2014,
            "title": "Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: Final analysis of a long-term follow-up study up to 9.4 years post-vaccination",
            "volume": "10"
        },
        "b0285": {
            "authors": [
                {
                    "first": "Johanna A.C.",
                    "initial": "J.A.C.",
                    "last": "Schalk"
                },
                {
                    "first": "Frits R.",
                    "initial": "F.R.",
                    "last": "Mooi"
                },
                {
                    "first": "Guy A.M.",
                    "initial": "G.A.M.",
                    "last": "Berbers"
                },
                {
                    "first": "Leon A.G.J.M.",
                    "initial": "L.A.G.J.M.",
                    "last": "Van Aerts"
                },
                {
                    "first": "Hans",
                    "initial": "H.",
                    "last": "Ovelg\u00f6nne"
                },
                {
                    "first": "Tjeerd G.",
                    "initial": "T.G.",
                    "last": "Kimman"
                }
            ],
            "doi": "10.4161/hv.2.2.2620",
            "firstpage": "45",
            "issn": "15548600",
            "lastpage": "53",
            "pmid": "17012886",
            "pub_year": 2006,
            "title": "Preclinical and clinical safety studies on DNA vaccines",
            "volume": "2"
        },
        "b0290": {
            "authors": [
                {
                    "first": "Brian J.",
                    "initial": "B.J.",
                    "last": "Ledwith"
                },
                {
                    "first": "Sujata",
                    "initial": "S.",
                    "last": "Manam"
                },
                {
                    "first": "Philip J.",
                    "initial": "P.J.",
                    "last": "Troilo"
                },
                {
                    "first": "Amy B.",
                    "initial": "A.B.",
                    "last": "Barnum"
                },
                {
                    "first": "Cindy J.",
                    "initial": "C.J.",
                    "last": "Pauley"
                },
                {
                    "first": "Thomas G.",
                    "initial": "T.G.",
                    "last": "Griffiths"
                },
                {
                    "first": "Laural B.",
                    "initial": "L.B.",
                    "last": "Harper"
                },
                {
                    "first": "Carolann M.",
                    "initial": "C.M.",
                    "last": "Beare"
                },
                {
                    "first": "Walter J.",
                    "initial": "W.J.",
                    "last": "Bagdon"
                },
                {
                    "first": "Warren W.",
                    "initial": "W.W.",
                    "last": "Nichols"
                }
            ],
            "doi": "10.1159/000053993",
            "firstpage": "258",
            "issn": "03005526",
            "lastpage": "272",
            "pmid": "11251381",
            "pub_year": 2000,
            "title": "Plasmid DNA vaccines: Investigation of integration into host cellular DNA following intramuscular injection in mice",
            "volume": "43"
        },
        "b0295": {
            "authors": [
                {
                    "first": "T. D.E.",
                    "initial": "T.D.E.",
                    "last": "Medjitna"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Stadler"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Bruckner"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Griot"
                },
                {
                    "first": "H. P.",
                    "initial": "H.P.",
                    "last": "Ottiger"
                }
            ],
            "firstpage": "261",
            "issn": "14246074",
            "lastpage": "270",
            "pmid": "17058502",
            "pub_year": 2006,
            "title": "DNA vaccines: Safety aspect assessment and regulation",
            "volume": "126"
        }
    },
    "body_text": [
        {
            "endOffset": 32793,
            "parents": [],
            "refoffsets": {
                "b0200": {
                    "endOffset": 32698,
                    "startOffset": 32694
                }
            },
            "secId": "s0095",
            "sentence": "Consequently, a greater stimulation of the immune system leading to more T cells and antibodies [40] to recognize the antigen, and successfully induce protection in a viral challenge is obtained.",
            "startOffset": 32598,
            "title": "Discussion"
        },
        {
            "endOffset": 28346,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Animals were infected by the intranasal route with a lethal dose of VACV, two weeks after the last immunization (Fig. 5A).",
            "startOffset": 28224,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 33734,
            "parents": [],
            "secId": "s0095",
            "sentence": "IFN-\u03b3 is the most common cytokine in a TH1-type response and is powerful for viral removal.",
            "startOffset": 33643,
            "title": "Discussion"
        },
        {
            "endOffset": 26611,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "In agreement with earlier times post-vaccination there was a significant increase in IFN-\u03b3 production in stimulated splenocytes from mice immunized with pA27LOPT or pA27LOPT + I, as compared to control groups.",
            "startOffset": 26402,
            "title": "Measuring the cytokine profile"
        },
        {
            "endOffset": 18813,
            "parents": [],
            "secId": "s0005",
            "sentence": "Our results show that our virus-free DNA vaccine induces memory immune responses, and significantly decreases viral replication and dissemination.",
            "startOffset": 18667,
            "title": "Introduction"
        },
        {
            "endOffset": 21836,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Spots-forming cells (SFCs) were quantified using an automated ELISPOT reader system from CTL Analyzers (Cleveland OH, USA) with the ImmunoSpot software.",
            "startOffset": 21684,
            "title": "IFN-\u03b3 ELISPOT assay"
        },
        {
            "endOffset": 34724,
            "parents": [],
            "secId": "s0095",
            "sentence": "This suggests that Imiquimod did not enhance the induction of immune responses in these set of experiments.",
            "startOffset": 34617,
            "title": "Discussion"
        },
        {
            "endOffset": 22344,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Specifically, the IgG (115-035-008), or IgG1 (115-035-205), or IgG2a (115-035-206) HRP-conjugated goat anti-mouse from Jackson Immunoresearch (West Grove, PA, USA) were used to detect the A27-specific antibody production.",
            "startOffset": 22123,
            "title": "Measurement of total IgG, IgG1 and IgG2a antibody response by ELISA"
        },
        {
            "endOffset": 31083,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 31069,
                    "startOffset": 31065
                }
            },
            "secId": "s0095",
            "sentence": "However, our objective in this study was to capture and correlate memory responses [28] to infection.",
            "startOffset": 30982,
            "title": "Discussion"
        },
        {
            "endOffset": 39519,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 39366,
                    "startOffset": 39362
                }
            },
            "secId": "s0095",
            "sentence": "Our previous [23] and current works show a codon-optimized vaccine to induce a significant enhancement of the immune response, compared to the non-adjuvanted formulation.",
            "startOffset": 39349,
            "title": "Discussion"
        },
        {
            "endOffset": 24512,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The one-way ANOVA test was used to determine the statistical significance of differences among groups, using the GraphPad Prism 6 (La Jolla, CA, USA).",
            "startOffset": 24362,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 28223,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "To address this issue, we examined VACV replication in vaccinated mice.",
            "startOffset": 28152,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 16941,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 16751,
                    "startOffset": 16748
                },
                "b0050": {
                    "endOffset": 16804,
                    "startOffset": 16800
                },
                "b0055": {
                    "endOffset": 16886,
                    "startOffset": 16879
                },
                "b0060": {
                    "endOffset": 16886,
                    "startOffset": 16879
                }
            },
            "secId": "s0005",
            "sentence": "However, the use of this vaccine is contraindicated [9] in individuals with a compromised immune system [10], patients receiving immune-suppressive therapy, and transplant recipients [11,12], in addition to those with a history of skin diseases.",
            "startOffset": 16696,
            "title": "Introduction"
        },
        {
            "endOffset": 26949,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "We studied the A27 antigen-specific humoral memory immune response, after vaccination with a codon-optimized pA27L formulated with or without Imiquimod (Fig. 4).",
            "startOffset": 26788,
            "title": "Humoral immune response analysis"
        },
        {
            "endOffset": 15873,
            "parents": [],
            "secId": "s0005",
            "sentence": "This virus is categorized as a Tier 1 select agent by the Federal Select Agent Program (CDC, USDA).",
            "startOffset": 15774,
            "title": "Introduction"
        },
        {
            "endOffset": 29073,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "In contrast, mice immunized with pA27LOPT or pA27LOPT + I showed a 10-fold reduction in viral titers in lungs as compared to na\u00efve mice (Fig. 5B).",
            "startOffset": 28927,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 23552,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The left lung from each individual mouse was homogenized using the TissueLyser LT from Qiagen (Valencia, CA, USA) with two cycles of 3 min at 501/S oscillation.",
            "startOffset": 23392,
            "title": "Intranasal challenge and virus titers in lung and ovaries"
        },
        {
            "endOffset": 29421,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Similar virus titers were observed in the ovaries of mice that were immunized with pVAX1, pVAX1+I or the non-codon optimized A27L-based plasmid (pA27L).",
            "startOffset": 29269,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 36059,
            "parents": [],
            "secId": "s0095",
            "sentence": "These effects would allow non-specific immune responses in the backbone-immunized animals to stand out.",
            "startOffset": 35956,
            "title": "Discussion"
        },
        {
            "endOffset": 18419,
            "parents": [],
            "secId": "s0005",
            "sentence": "Consequently, the greater production of protein leads to a better stimulus for the immune system.",
            "startOffset": 18322,
            "title": "Introduction"
        },
        {
            "endOffset": 36623,
            "parents": [],
            "secId": "s0095",
            "sentence": "Our major interest is to produce a vaccine against smallpox suitable for worldwide distribution, including developing countries.",
            "startOffset": 36495,
            "title": "Discussion"
        },
        {
            "endOffset": 20918,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 20917,
                    "startOffset": 20913
                }
            },
            "secId": "s0025",
            "sentence": "The vaccine was formulated at a DNA concentration of 1.0 mg/mL in a 0.15 M sodium citrate buffer and 0.25% bupivacaine [23].",
            "startOffset": 20794,
            "title": "Study design"
        },
        {
            "endOffset": 30059,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "These data indicate that our vaccine formulation was able to limit both, replication and spread in experimental groups, as compared to control groups.",
            "startOffset": 29909,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 37193,
            "parents": [],
            "refoffsets": {
                "b0255": {
                    "endOffset": 37192,
                    "startOffset": 37188
                }
            },
            "secId": "s0095",
            "sentence": "Also, using a novel skin electroporation device, a DNA vaccine containing four different antigens of vaccinia was reported to induce protection after intranasal poxvirus challenge [51].",
            "startOffset": 37008,
            "title": "Discussion"
        },
        {
            "endOffset": 38654,
            "parents": [],
            "secId": "s0095",
            "sentence": "Moreover, single-antigen vaccination has not been designed only for vaccines against smallpox, nor is limited for experimental vaccines.",
            "startOffset": 38518,
            "title": "Discussion"
        },
        {
            "endOffset": 35204,
            "parents": [],
            "secId": "s0095",
            "sentence": "Also, adjuvant degradation could explain this effect.",
            "startOffset": 35151,
            "title": "Discussion"
        },
        {
            "endOffset": 37898,
            "parents": [],
            "secId": "s0095",
            "sentence": "Moreover, a formulation consisting of a single-antigen vaccine would accomplish the worldwide public health requirement of inexpensive production and simple distribution among several countries.",
            "startOffset": 37704,
            "title": "Discussion"
        },
        {
            "endOffset": 31865,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 31864,
                    "startOffset": 31860
                }
            },
            "secId": "s0095",
            "sentence": "On this matter, a DNA-based vaccine consisting of A27L in addition to DNA coding for A33R, L1R, and B5R demonstrate to protect against a monkeypox challenge [31].",
            "startOffset": 31703,
            "title": "Discussion"
        },
        {
            "endOffset": 33211,
            "parents": [],
            "secId": "s0095",
            "sentence": "In this regard, our data shows pA27LOPT or pA27LOPT + I to significantly increase the frequency of cells producing IFN-\u03b3 over time, compared to controls.",
            "startOffset": 33058,
            "title": "Discussion"
        },
        {
            "endOffset": 23817,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Infected cell lysate from lung and ovaries harvested from different groups of mice were used to detect the viral load.",
            "startOffset": 23699,
            "title": "Viral plaque assay"
        },
        {
            "endOffset": 27518,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "The two antibodies of greatest interest to us were IgG2a (opsonizing antibodies that support a TH1 type response) and IgG1 (neutralizing IgG1 antibodies that support a TH2 type response).",
            "startOffset": 27331,
            "title": "IgG1 and IgG2a Isotypes antibody detection"
        },
        {
            "endOffset": 21219,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Then, 15 ml of RPMI media was added to stop the red blood cells lysis.",
            "startOffset": 21149,
            "title": "Splenocytes preparation"
        },
        {
            "endOffset": 25637,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Vaccination with pVAX1, either alone or with Imiquimod, increased the number of stimulated splenocytes, possibly due to a non-specific DNA effect on T cell responses.",
            "startOffset": 25471,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 38790,
            "parents": [],
            "refoffsets": {
                "b0270": {
                    "endOffset": 38735,
                    "startOffset": 38731
                },
                "b0275": {
                    "endOffset": 38754,
                    "startOffset": 38750
                }
            },
            "secId": "s0095",
            "sentence": "In this regard, two Hepatitis B virus (HBV) vaccine known as Recombivax-HB\u00ae [54] and Engerix-B [55] are licensed are in use in the USA.",
            "startOffset": 38655,
            "title": "Discussion"
        },
        {
            "endOffset": 16695,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 16694,
                    "startOffset": 16691
                }
            },
            "secId": "s0005",
            "sentence": "According to the CDC, in the event of a smallpox emergency, the U.S. government has enough vaccine available to immunize every person in the United States [8].",
            "startOffset": 16536,
            "title": "Introduction"
        },
        {
            "endOffset": 33576,
            "parents": [],
            "secId": "s0095",
            "sentence": "In this regard, we found higher IgG2a and IgG1 in pA27LOPT and pA27LOPT immunized groups compared to controls.",
            "startOffset": 33466,
            "title": "Discussion"
        },
        {
            "endOffset": 34616,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 34615,
                    "startOffset": 34611
                }
            },
            "secId": "s0095",
            "sentence": "Specifically, no significant differences in the immune response were observed between pA27LOPT and pA27LOPT + I immunized groups, as opposed to our previous report [23].",
            "startOffset": 34447,
            "title": "Discussion"
        },
        {
            "endOffset": 35752,
            "parents": [],
            "secId": "s0095",
            "sentence": "As stated before, the intense immune response observed with the optimized plasmid at some point could trigger a regulatory effect that induces a stronger rate of decay in antigen-specific immune responses, compared to non-specific responses.",
            "startOffset": 35511,
            "title": "Discussion"
        },
        {
            "endOffset": 21148,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Cells were filtered, centrifuged, and incubated for 1 min with 1 mL of lysing buffer (Sigma Aldrich, St. Louis MO, USA).",
            "startOffset": 21028,
            "title": "Splenocytes preparation"
        },
        {
            "endOffset": 28068,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Our A27L-based DNA vaccine induced both T- and B-cell mediated immunity at the time of infection.",
            "startOffset": 27971,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 34446,
            "parents": [],
            "secId": "s0095",
            "sentence": "We expected that the differences in the timing of sampling to have an impact in the results.",
            "startOffset": 34354,
            "title": "Discussion"
        },
        {
            "endOffset": 18026,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 18025,
                    "startOffset": 18021
                }
            },
            "secId": "s0005",
            "sentence": "Previously, we reported a potential DNA-based vaccine against smallpox consisting of the codon-optimized A27L gene (pA27LOPT) from the VACV Western Reserve strain [23].",
            "startOffset": 17858,
            "title": "Introduction"
        },
        {
            "endOffset": 19687,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For the challenge experiments and the intranasal inoculation experiments, the control groups consisted of 3 mice, while the experimental groups consisted of 6 mice.",
            "startOffset": 19523,
            "title": "Mice"
        },
        {
            "endOffset": 16535,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 16487,
                    "startOffset": 16482
                },
                "b0020": {
                    "endOffset": 16435,
                    "startOffset": 16430
                },
                "b0025": {
                    "endOffset": 16435,
                    "startOffset": 16430
                },
                "b0030": {
                    "endOffset": 16435,
                    "startOffset": 16430
                },
                "b0035": {
                    "endOffset": 16487,
                    "startOffset": 16482
                }
            },
            "secId": "s0005",
            "sentence": "Moreover, encephalitis [3\u20136], severe skin infections [3,7], and even death [3,7] were observed after administering this vaccine.",
            "startOffset": 16407,
            "title": "Introduction"
        },
        {
            "endOffset": 26076,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "In summary, these data indicate that the A27L-based DNA vaccine possesses beneficial immunomodulatory properties because it significantly increased the frequency of cells that secrete IFN-\u03b3 in response to the A27 antigen.",
            "startOffset": 25855,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 29908,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "While all lungs possessed detectable VACV (Fig. 5B), VACV was detected in the ovaries of only four or three mice immunized with pA27LOPT or pA27LOPT + I, respectively (Fig. 5C).",
            "startOffset": 29731,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 17858,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 17857,
                    "startOffset": 17850
                },
                "b0105": {
                    "endOffset": 17857,
                    "startOffset": 17850
                },
                "b0110": {
                    "endOffset": 17857,
                    "startOffset": 17850
                }
            },
            "secId": "s0005",
            "sentence": "There are several studies in which these types of vaccines have shown to be effective, without adverse effects on the recipient organism [20\u201322].",
            "startOffset": 17713,
            "title": "Introduction"
        },
        {
            "endOffset": 28151,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "One question is if this immunity would be beneficial against a poxvirus infection.",
            "startOffset": 28069,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 18321,
            "parents": [],
            "refoffsets": {
                "b0120": {
                    "endOffset": 18320,
                    "startOffset": 18313
                },
                "b0125": {
                    "endOffset": 18320,
                    "startOffset": 18313
                }
            },
            "secId": "s0005",
            "sentence": "This codon-optimization approach has been demonstrated to enhance the immune response in many cases by an apparent increase in protein production or expression [24,25].",
            "startOffset": 18153,
            "title": "Introduction"
        },
        {
            "endOffset": 19226,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Female BALB/c mice between 4 and 6-week-old purchased from Charles River (Wilmington, MA, USA) were housed at the University of Puerto Rico Medical Sciences Campus (Memory Immune Response experiment) or the University of Illinois at Urbana-Champaign (VACV intranasal infection).",
            "startOffset": 18948,
            "title": "Mice"
        },
        {
            "endOffset": 36192,
            "parents": [],
            "secId": "s0095",
            "sentence": "Again, additional studies beyond the scope of this work are needed to explain the variations in the rates of these immune responses.",
            "startOffset": 36060,
            "title": "Discussion"
        },
        {
            "endOffset": 39206,
            "parents": [],
            "refoffsets": {
                "b0285": {
                    "endOffset": 39205,
                    "startOffset": 39198
                },
                "b0290": {
                    "endOffset": 39101,
                    "startOffset": 39094
                },
                "b0295": {
                    "endOffset": 39205,
                    "startOffset": 39198
                }
            },
            "secId": "s0095",
            "sentence": "Although DNA vaccines have been shown to be safe in animals and humans, [57,58] a future study must be conducted with our vaccine candidate to address possible safety concerns [57,59].",
            "startOffset": 39022,
            "title": "Discussion"
        },
        {
            "endOffset": 21358,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Finally, cells were centrifuged and diluted for counting and analysis.",
            "startOffset": 21288,
            "title": "Splenocytes preparation"
        },
        {
            "endOffset": 34354,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 34353,
                    "startOffset": 34346
                },
                "b0220": {
                    "endOffset": 34353,
                    "startOffset": 34346
                }
            },
            "secId": "s0095",
            "sentence": "This information confirms the potential of our single antigen DNA vaccine enhancing a TH1-biased humoral response, which is known to be essential against viral infections [43,44].",
            "startOffset": 34175,
            "title": "Discussion"
        },
        {
            "endOffset": 20697,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Female BALB/c mice were either not immunized (na\u00efve) or immunized intramuscularly three times, at two week intervals with either 100 \u00b5g pVAX1 (vector), 100 \u00b5g pVAX1 + 50 nmoles of Imiquimod, 100 \u00b5g pA27LOPT, or 100 \u00b5g pA27LOPT + 50 nmoles of Imiquimod.",
            "startOffset": 20445,
            "title": "Study design"
        },
        {
            "endOffset": 16263,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 16220,
                    "startOffset": 16217
                }
            },
            "secId": "s0005",
            "sentence": "ACAM2000 is the current smallpox vaccine [2], consisting of live vaccinia virus (VACV).",
            "startOffset": 16176,
            "title": "Introduction"
        },
        {
            "endOffset": 18666,
            "parents": [],
            "secId": "s0005",
            "sentence": "Since the immune response to our novel vaccine formulation is favorable, in the present study, we investigated if the elicited immune response was maintained over time, and if vaccination could protect against infection with a lethal dose of VACV.",
            "startOffset": 18419,
            "title": "Introduction"
        },
        {
            "endOffset": 30836,
            "parents": [],
            "secId": "s0095",
            "sentence": "Here, we present evidence that this same vaccine formulation also produces an adaptive immune response, which substantially decreased viral replication and spread.",
            "startOffset": 30673,
            "title": "Discussion"
        },
        {
            "endOffset": 15937,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 15936,
                    "startOffset": 15933
                }
            },
            "secId": "s0005",
            "sentence": "Routine smallpox vaccination was discontinued in the 1970s [1].",
            "startOffset": 15874,
            "title": "Introduction"
        },
        {
            "endOffset": 19857,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Each animal was anesthetized with a mixture of Ketamine and Xylazine by an intraperitoneal injection, and euthanized via cervical dislocation to perform the experiments.",
            "startOffset": 19688,
            "title": "Mice"
        },
        {
            "endOffset": 17508,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 17507,
                    "startOffset": 17498
                },
                "b0080": {
                    "endOffset": 17507,
                    "startOffset": 17498
                },
                "b0085": {
                    "endOffset": 17507,
                    "startOffset": 17498
                },
                "b0090": {
                    "endOffset": 17507,
                    "startOffset": 17498
                }
            },
            "secId": "s0005",
            "sentence": "DNA vaccines are safe, inexpensive, easy to transport, manage and store; criteria that a good vaccine must meet [9,16\u201318].",
            "startOffset": 17386,
            "title": "Introduction"
        },
        {
            "endOffset": 22891,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 22772,
                    "startOffset": 22768
                }
            },
            "secId": "s0045",
            "sentence": "Then, the supernatants were used to detect secreted IFN-\u03b3 or IL-4 cytokines, as previously described [23], using the commercially available Quantikine Mouse IFN-\u03b3 or IL-4 immunoassays from R&D Systems (Minneapolis, MN, USA).",
            "startOffset": 22667,
            "title": "Measurement of cytokine production"
        },
        {
            "endOffset": 35955,
            "parents": [],
            "secId": "s0095",
            "sentence": "Also, a decline in the immune response simply due to the passage of time after vaccination is an expected effect that could account for the decrease in the signals obtained two weeks after immunization.",
            "startOffset": 35753,
            "title": "Discussion"
        },
        {
            "endOffset": 40045,
            "parents": [],
            "secId": "s0095",
            "sentence": "Based on that information, we expect the significant enhancement of our codon-optimized plasmid to overcome the need of using a multi-epitope approach.",
            "startOffset": 39894,
            "title": "Discussion"
        },
        {
            "endOffset": 26316,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 26222,
                    "startOffset": 26218
                }
            },
            "secId": "s0075",
            "sentence": "Previously, we reported that our vaccine formulation triggered a significant increase in the levels of IFN-\u03b3 [23] but not IL-4, suggesting that A27-based DNA vaccines skewed a TH1 response after vaccination.",
            "startOffset": 26109,
            "title": "Measuring the cytokine profile"
        },
        {
            "endOffset": 16014,
            "parents": [],
            "secId": "s0005",
            "sentence": "Consequently, the general population is currently unprotected or vulnerable.",
            "startOffset": 15938,
            "title": "Introduction"
        },
        {
            "endOffset": 20430,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "After large scale production, plasmids were purified using the Qiagen Plasmid Giga kit (Germantown, MD, USA) following the manufacturer\u2019s instructions.",
            "startOffset": 20279,
            "title": "Vaccine design and plasmid purification"
        },
        {
            "endOffset": 24361,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "The data from experiments shown here were repeated at least three times and are presented as the mean \u00b1 standard error of the mean (SEM).",
            "startOffset": 24224,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 19908,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Each experiment was repeated at least three times.",
            "startOffset": 19858,
            "title": "Mice"
        },
        {
            "endOffset": 38518,
            "parents": [],
            "refoffsets": {
                "b0265": {
                    "endOffset": 38517,
                    "startOffset": 38513
                }
            },
            "secId": "s0095",
            "sentence": "In an additional report, the investigators used the A33R clone as the antigen, and they also showed 100% protection after intranasal challenge in mice [53].",
            "startOffset": 38362,
            "title": "Discussion"
        },
        {
            "endOffset": 17259,
            "parents": [],
            "secId": "s0005",
            "sentence": "DNA vaccination is a safe alternative to induce protection, and to stimulate high immune responses without the adverse effects of a live virus vaccine immunization.",
            "startOffset": 17095,
            "title": "Introduction"
        },
        {
            "endOffset": 39747,
            "parents": [],
            "secId": "s0095",
            "sentence": "Moreover, our results were obtained using three doses of a single antigen vaccine without the aid of additional live-vectors, delivery systems, and novel equipment such as gene guns, electroporation, or skin tattooing machines.",
            "startOffset": 39520,
            "title": "Discussion"
        },
        {
            "endOffset": 20278,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The resulting plasmids were transformed individually in the E. coli Top10 strain (Invitrogen, Grand Island, NY, USA).",
            "startOffset": 20161,
            "title": "Vaccine design and plasmid purification"
        },
        {
            "endOffset": 23206,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Two weeks after the third immunization, mice were anesthetized with isoflurane (5% in O2) inhalation using a vaporizer unit (Vetland, Louisville, KY) and inoculated with 2.5 \u00d7 106 PFU of sucrose density gradient purified VACV in 20 \u00b5l (10 \u00b5l per nostril).",
            "startOffset": 22951,
            "title": "Intranasal challenge and virus titers in lung and ovaries"
        },
        {
            "endOffset": 32208,
            "parents": [],
            "secId": "s0095",
            "sentence": "In our study, we demonstrate that a codon-optimized A27L gene is sufficient to mount protective immune responses, without the hazard of using a live vector.",
            "startOffset": 32052,
            "title": "Discussion"
        },
        {
            "endOffset": 39349,
            "parents": [],
            "secId": "s0095",
            "sentence": "Furthermore, we also want to assess the capacity of our DNA vaccine of inducing protection against a monkeypox challenge in nonhuman primates.",
            "startOffset": 39207,
            "title": "Discussion"
        },
        {
            "endOffset": 38361,
            "parents": [],
            "refoffsets": {
                "b0260": {
                    "endOffset": 38360,
                    "startOffset": 38356
                }
            },
            "secId": "s0095",
            "sentence": "Other investigators delivered B5R as a DNA vaccine, inducing not only a strong interferon gamma (IFN-\u03b3) response in BALB/c mice, but also 100% protection [52].",
            "startOffset": 38202,
            "title": "Discussion"
        },
        {
            "endOffset": 32597,
            "parents": [],
            "secId": "s0095",
            "sentence": "All these modifications are intended to improve gene stability and protein expression.",
            "startOffset": 32511,
            "title": "Discussion"
        },
        {
            "endOffset": 17385,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 17384,
                    "startOffset": 17377
                },
                "b0070": {
                    "endOffset": 17384,
                    "startOffset": 17377
                },
                "b0075": {
                    "endOffset": 17384,
                    "startOffset": 17377
                }
            },
            "secId": "s0005",
            "sentence": "This type of vaccine has proven to be very effective in stimulating protective immune responses in several organisms [13\u201315].",
            "startOffset": 17260,
            "title": "Introduction"
        },
        {
            "endOffset": 22666,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Two weeks after the third immunization, splenocytes from immunized mice were stimulated for five days at 37 \u00b0C, in 5% CO2 with a pool of 25 overlapping peptides from VACV A27 protein (JPT Peptide Technologies, Berlin, Germany) diluted to a concentration of 0.5 mg/mL in culture medium.",
            "startOffset": 22381,
            "title": "Measurement of cytokine production"
        },
        {
            "endOffset": 33643,
            "parents": [],
            "secId": "s0095",
            "sentence": "Moreover, IgG2a was the prominent antibody under those conditions.",
            "startOffset": 33577,
            "title": "Discussion"
        },
        {
            "endOffset": 32052,
            "parents": [],
            "refoffsets": {
                "b0160": {
                    "endOffset": 32051,
                    "startOffset": 32047
                }
            },
            "secId": "s0095",
            "sentence": "More recently, a recombinant adenovirus-based vaccine encoding A27L, administered as a single intramuscular injection, protected mice against a lethal intranasal poxvirus challenge [32].",
            "startOffset": 31866,
            "title": "Discussion"
        },
        {
            "endOffset": 17712,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 17711,
                    "startOffset": 17704
                },
                "b0095": {
                    "endOffset": 17711,
                    "startOffset": 17704
                }
            },
            "secId": "s0005",
            "sentence": "Another advantage of DNA vaccines is that they penetrate the interior of the cell to emulate a viral infection so that the antigens are presented and recognized by the immune system like a virus [15,19].",
            "startOffset": 17509,
            "title": "Introduction"
        },
        {
            "endOffset": 28696,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Whereas animals vaccinated with pVAX1 or pVAX1 + I showed a slight decrease in viral titers as compared to na\u00efve mice.",
            "startOffset": 28578,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 37362,
            "parents": [],
            "secId": "s0095",
            "sentence": "We are aware that several investigators are testing a multi-epitope approach in their vaccine design in order to broad the spectrum of recognized antigenic determinants.",
            "startOffset": 37193,
            "title": "Discussion"
        },
        {
            "endOffset": 37703,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 37533,
                    "startOffset": 37529
                }
            },
            "secId": "s0095",
            "sentence": "However, as the A27L gene is highly conserved among poxviruses [29], not only our group, but also other investigators design single-antigen vaccines against smallpox, expecting to induce a protective cross-reaction between VACV and VARV.",
            "startOffset": 37466,
            "title": "Discussion"
        },
        {
            "endOffset": 32891,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 32890,
                    "startOffset": 32886
                }
            },
            "secId": "s0095",
            "sentence": "Both humoral and cellular immune responses are essential for the protection against smallpox [26].",
            "startOffset": 32793,
            "title": "Discussion"
        },
        {
            "endOffset": 17095,
            "parents": [],
            "secId": "s0005",
            "sentence": "For this vast number of people, being vaccinated with the available vaccine represents life-threatening outcomes that exceed the benefits of vaccination.",
            "startOffset": 16942,
            "title": "Introduction"
        },
        {
            "endOffset": 19448,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "All animal experiments and procedures were approved by the Institutional Animal Care and Use Committee at both institutions.",
            "startOffset": 19324,
            "title": "Mice"
        },
        {
            "endOffset": 37465,
            "parents": [],
            "secId": "s0095",
            "sentence": "With this approach, they expect to induce a higher diversity of antibodies and CTLs to target Variola.",
            "startOffset": 37363,
            "title": "Discussion"
        },
        {
            "endOffset": 23391,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "Mice organs were harvested one week after inoculation.",
            "startOffset": 23337,
            "title": "Intranasal challenge and virus titers in lung and ovaries"
        },
        {
            "endOffset": 34949,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 34948,
                    "startOffset": 34941
                },
                "b0230": {
                    "endOffset": 34948,
                    "startOffset": 34941
                },
                "b0235": {
                    "endOffset": 34948,
                    "startOffset": 34941
                },
                "b0240": {
                    "endOffset": 34948,
                    "startOffset": 34941
                }
            },
            "secId": "s0095",
            "sentence": "We speculate that the intense immune response produced after vaccination with the optimized plasmid, at some point triggers a regulatory effect when combined with the adjuvant as a result of excessive epitope levels [45\u201348].",
            "startOffset": 34725,
            "title": "Discussion"
        },
        {
            "endOffset": 20793,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Also, 100 \u00b5g of the non-codon optimized pA27L were included in the viral challenge experiments.",
            "startOffset": 20698,
            "title": "Study design"
        },
        {
            "endOffset": 31221,
            "parents": [],
            "secId": "s0095",
            "sentence": "For that reason, the immune response was measured two weeks after the last immunization, coinciding with the time of the viral challenge.",
            "startOffset": 31084,
            "title": "Discussion"
        },
        {
            "endOffset": 23678,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The left ovary was homogenized using the 1.5 Kimble\u2122 BioMasherII\u2122 tissue homogenizer from Fisher Scientific (Cayey, PR, USA).",
            "startOffset": 23553,
            "title": "Intranasal challenge and virus titers in lung and ovaries"
        },
        {
            "endOffset": 27148,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "In this ELISA, we used the VACV A27 protein as an antigen, and an IgG capture antibody to quantify A27-specific antibody production induced by our DNA vaccine, two weeks after the third vaccination.",
            "startOffset": 26950,
            "title": "Humoral immune response analysis"
        },
        {
            "endOffset": 21287,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "If lysis is incomplete, incubation with the buffer may be repeated.",
            "startOffset": 21220,
            "title": "Splenocytes preparation"
        },
        {
            "endOffset": 35510,
            "parents": [],
            "secId": "s0095",
            "sentence": "Also, we observe high levels of non-specific cell-mediated immune responses in animals immunized with backbone vector.",
            "startOffset": 35392,
            "title": "Discussion"
        },
        {
            "endOffset": 37007,
            "parents": [],
            "refoffsets": {
                "b0250": {
                    "endOffset": 37006,
                    "startOffset": 37002
                }
            },
            "secId": "s0095",
            "sentence": "In other study, vaccination with both L1R and A33R gene of vaccinia virus using the gene gun technique, induce protection against lethal challenge [50].",
            "startOffset": 36855,
            "title": "Discussion"
        },
        {
            "endOffset": 27773,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Moreover, in these experiments IgG2a was the outstanding produced antibody.",
            "startOffset": 27698,
            "title": "IgG1 and IgG2a Isotypes antibody detection"
        },
        {
            "endOffset": 33057,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 33056,
                    "startOffset": 33049
                },
                "b0210": {
                    "endOffset": 33056,
                    "startOffset": 33049
                }
            },
            "secId": "s0095",
            "sentence": "The T cell-mediated immune response is necessary for the delay in the illness progression, and the humoral-mediated response is critical for virus clearance [41,42].",
            "startOffset": 32892,
            "title": "Discussion"
        },
        {
            "endOffset": 29730,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Interestingly, in addition to a decreased replication, a limited spread of VACV was observed in ovaries of mice immunized with pA27LOPT or pA27LOPT + I.",
            "startOffset": 29578,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 29577,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "However, mice immunized with pA27LOPT or pA27LOPT + I showed a 10,000-fold or 1000-fold reduction in virus titers, respectively, as compared to na\u00efve mice.",
            "startOffset": 29422,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 31473,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 31472,
                    "startOffset": 31468
                }
            },
            "secId": "s0095",
            "sentence": "Opposed to our initial concern that the immune response might have fade two weeks after immunization, these data confirm not only the presence of antigen-specific immune responses, but also protection against a viral challenge at that time point [28].",
            "startOffset": 31222,
            "title": "Discussion"
        },
        {
            "endOffset": 19323,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The animal care was performed under National Institute of Health guidelines (Bethesda, MD, USA).",
            "startOffset": 19227,
            "title": "Mice"
        },
        {
            "endOffset": 21898,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The data were expressed as mean \u00b1 standard error of the mean.",
            "startOffset": 21837,
            "title": "IFN-\u03b3 ELISPOT assay"
        },
        {
            "endOffset": 25854,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Our data shows a statistically significant increase in T cell responses when A27L DNA was present versus absent.",
            "startOffset": 25742,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 31584,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 31583,
                    "startOffset": 31576
                },
                "b0150": {
                    "endOffset": 31583,
                    "startOffset": 31576
                }
            },
            "secId": "s0095",
            "sentence": "The A27L gene is an attractive basis for a DNA vaccine, as its gene product is known to be immunogenic [29,30].",
            "startOffset": 31473,
            "title": "Discussion"
        },
        {
            "endOffset": 28926,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Mice immunized with a plasmid encoding a non-codon optimized A27L showed no difference in virus titers as compared to na\u00efve mice, demonstrating that A27L without codon-optimization provides no protection against VACV replication.",
            "startOffset": 28697,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 30672,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 30671,
                    "startOffset": 30667
                }
            },
            "secId": "s0095",
            "sentence": "With the intent to develop a virus-free vaccine, which is expected to be safe for all humans, we previously reported a DNA vaccine coding for the VACV A27L gene that induces strong T- and B-cell immune responses in mice soon after vaccination [23].",
            "startOffset": 30424,
            "title": "Discussion"
        },
        {
            "endOffset": 16406,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 16405,
                    "startOffset": 16402
                }
            },
            "secId": "s0005",
            "sentence": "ACAM2000 causes serious complications such as eczema vaccinatum and progressive vaccinia in people with previously reported skin diseases [3].",
            "startOffset": 16264,
            "title": "Introduction"
        },
        {
            "endOffset": 34066,
            "parents": [],
            "secId": "s0095",
            "sentence": "Although we observe lower frequencies of IFN-\u03b3 producing cells in this study compared to our previous publication, as determined by ELISPOT, our ELISA analysis shows this decrease not to affect the amount of cytokine released.",
            "startOffset": 33840,
            "title": "Discussion"
        },
        {
            "endOffset": 27909,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "These data suggest that our DNA vaccination cocktail induces the generation of opsonizing antibodies, supporting a TH1 biased response.",
            "startOffset": 27774,
            "title": "IgG1 and IgG2a Isotypes antibody detection"
        },
        {
            "endOffset": 36854,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 36853,
                    "startOffset": 36846
                },
                "b0245": {
                    "endOffset": 36853,
                    "startOffset": 36846
                }
            },
            "secId": "s0095",
            "sentence": "Studies show other investigators to successfully design DNA vaccines, using single antigens like D8L or a combination of A27L, A33R, L1R and B5R vaccinia genes, able to induce protection against a vaccinia virus challenge [31,49].",
            "startOffset": 36624,
            "title": "Discussion"
        },
        {
            "endOffset": 26670,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "In contrast, IL-4 secretion was not detected in any group.",
            "startOffset": 26612,
            "title": "Measuring the cytokine profile"
        },
        {
            "endOffset": 25005,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "As controls, other mice were either not immunized (na\u00efve), or immunized with pVAX1 in the presence or absence of Imiquimod (I).",
            "startOffset": 24878,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 38893,
            "parents": [],
            "refoffsets": {
                "b0280": {
                    "endOffset": 38892,
                    "startOffset": 38888
                }
            },
            "secId": "s0095",
            "sentence": "Also, a prophylactic Human Papilloma Virus (HPV) vaccine known as Cervarix is currently licensed [56].",
            "startOffset": 38791,
            "title": "Discussion"
        },
        {
            "endOffset": 15773,
            "parents": [],
            "secId": "s0005",
            "sentence": "Variola virus (VARV), a member of the Poxviridae family and causative agent of smallpox, is considered one of the most devastating infectious agents of all times.",
            "startOffset": 15611,
            "title": "Introduction"
        },
        {
            "endOffset": 33465,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 33464,
                    "startOffset": 33457
                },
                "b0220": {
                    "endOffset": 33464,
                    "startOffset": 33457
                }
            },
            "secId": "s0095",
            "sentence": "In addition, the polarization of antibodies produced after an immunization is critical in the outcome of a humoral response [43,44].",
            "startOffset": 33333,
            "title": "Discussion"
        },
        {
            "endOffset": 33839,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 33838,
                    "startOffset": 33831
                },
                "b0220": {
                    "endOffset": 33838,
                    "startOffset": 33831
                }
            },
            "secId": "s0095",
            "sentence": "This cytokine promotes IgG2a class switching, which is beneficial against most viral infections [43,44].",
            "startOffset": 33735,
            "title": "Discussion"
        },
        {
            "endOffset": 27697,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "When examining IgG2a and IgG1 in vaccinated mice, the amount of both antibodies, were significantly higher in the experimental groups as compared to the control groups (Fig. 4B).",
            "startOffset": 27519,
            "title": "IgG1 and IgG2a Isotypes antibody detection"
        },
        {
            "endOffset": 38110,
            "parents": [],
            "refoffsets": {
                "b0260": {
                    "endOffset": 38109,
                    "startOffset": 38105
                }
            },
            "secId": "s0095",
            "sentence": "In this regard, Pulford et al. analyzed ten different genes of Vaccinia virus individually and found B5R, A33R, and A27L to induce a survival of or greater than 66% in a challenge, after four vaccine doses [52].",
            "startOffset": 37899,
            "title": "Discussion"
        },
        {
            "endOffset": 39022,
            "parents": [],
            "secId": "s0095",
            "sentence": "Therefore, vaccines based on a single-antigen are not only in development, but also currently used in several licensed vaccines.",
            "startOffset": 38894,
            "title": "Discussion"
        },
        {
            "endOffset": 25470,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "As expected, there were very low amounts of A27-specific T cells in na\u00efve mice.",
            "startOffset": 25391,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 25741,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "However, the response was further increased in mice vaccinated with pA27LOPT or pA27LOPT + I, (Fig. 2).",
            "startOffset": 25638,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 30981,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 30862,
                    "startOffset": 30858
                }
            },
            "secId": "s0095",
            "sentence": "In our previous study [23] the response was measured one week after the last immunization, to describe the immune effects soon after vaccination.",
            "startOffset": 30836,
            "title": "Discussion"
        },
        {
            "endOffset": 39893,
            "parents": [],
            "secId": "s0095",
            "sentence": "These devices could be a disadvantage if vaccines are intended to be administered to a large group of people, and distributed to other countries.",
            "startOffset": 39748,
            "title": "Discussion"
        },
        {
            "endOffset": 34174,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 34173,
                    "startOffset": 34169
                }
            },
            "secId": "s0095",
            "sentence": "Conversely, the release of IFN-\u03b3 increased for the experimental groups compared to the previous study [23].",
            "startOffset": 34067,
            "title": "Discussion"
        },
        {
            "endOffset": 33332,
            "parents": [],
            "secId": "s0095",
            "sentence": "Also, pA27LOPT- or pA27LOPT + I-immunized animals generated a higher A27L-specific humoral response compared to controls.",
            "startOffset": 33211,
            "title": "Discussion"
        },
        {
            "endOffset": 35150,
            "parents": [],
            "secId": "s0095",
            "sentence": "We interpret this effect to induce either a higher rate of signal decay or to establish a top ceiling in the increase of the signals obtained from the adjuvanted group compared to non-adjuvanted mice.",
            "startOffset": 34950,
            "title": "Discussion"
        },
        {
            "endOffset": 25216,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Two weeks after the last immunization (Fig. 1), splenocytes from each group of mice were pooled and stimulated, using a mix of overlapping peptides corresponding to the complete sequence of the VACV A27 protein.",
            "startOffset": 25005,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 29268,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 29267,
                    "startOffset": 29263
                }
            },
            "secId": "s0090",
            "sentence": "In na\u00efve mice, VACV disseminated from the lungs and replicated in the ovaries, as previously shown [26].",
            "startOffset": 29164,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 36495,
            "parents": [],
            "secId": "s0095",
            "sentence": "It is important to highlight that even with an increase in non-specific responses, signals from vaccine-immunized mice are significantly higher compared to those obtained from the backbone controls, and these non-specific responses do not correlate with a significant decrease in the viral load assays.",
            "startOffset": 36193,
            "title": "Discussion"
        },
        {
            "endOffset": 22122,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 22121,
                    "startOffset": 22117
                }
            },
            "secId": "s0040",
            "sentence": "The humoral immune response was analyzed two weeks after the third vaccination by Enzyme-Linked Immunosorbent Assay (ELISA), as previously described [23].",
            "startOffset": 21968,
            "title": "Measurement of total IgG, IgG1 and IgG2a antibody response by ELISA"
        },
        {
            "endOffset": 25390,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The mean frequency of the spot-forming cells (SFC) per million splenocytes are shown in Fig. 2.",
            "startOffset": 25295,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 18152,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 18151,
                    "startOffset": 18147
                }
            },
            "secId": "s0005",
            "sentence": "This vaccine induces significant humoral and cellular immune responses with and without the chemical adjuvant Imiquimod [23].",
            "startOffset": 18027,
            "title": "Introduction"
        },
        {
            "endOffset": 29163,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Similar trends were observed when viral replication was assessed in the ovaries (Fig. 5C).",
            "startOffset": 29073,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 32510,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 32300,
                    "startOffset": 32293
                },
                "b0170": {
                    "endOffset": 32300,
                    "startOffset": 32293
                },
                "b0175": {
                    "endOffset": 32343,
                    "startOffset": 32339
                },
                "b0180": {
                    "endOffset": 32399,
                    "startOffset": 32395
                },
                "b0185": {
                    "endOffset": 32452,
                    "startOffset": 32445
                },
                "b0190": {
                    "endOffset": 32452,
                    "startOffset": 32445
                },
                "b0195": {
                    "endOffset": 32509,
                    "startOffset": 32505
                }
            },
            "secId": "s0095",
            "sentence": "Among the modifications made to the sequence includes: (1) codon usage optimization [33,34], (2) elimination of certain DNA motif [35], (3) adjustment guanosine-cytosine (G-C) base pair [36], (4) replacement of the sequence repetitions [37,38], and (5) decrease possible RNA secondary structures [39].",
            "startOffset": 32209,
            "title": "Discussion"
        },
        {
            "endOffset": 24047,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Serial dilutions ranging from 10\u22121 to 10\u22126 were added to confluent monolayers of Vero cells in 6-well plates for 1 h. Cell lysates were removed and each well was covered with 2 ml of freshly prepared MEM supplemented with 2% FBS.",
            "startOffset": 23818,
            "title": "Viral plaque assay"
        },
        {
            "endOffset": 25295,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "A27-specfic T cell responses were measured by using ELISPOT analysis (Fig. 2).",
            "startOffset": 25217,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 38201,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 38200,
                    "startOffset": 38196
                }
            },
            "secId": "s0095",
            "sentence": "In another study, A27 administered as a single protein was used to induce protection [29].",
            "startOffset": 38111,
            "title": "Discussion"
        },
        {
            "endOffset": 24877,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The capacity of pA27LOPT, either alone or in the presence of Imiquimod, to induce protective immune responses was assessed by immunizing BALB/c mice three times, two weeks apart.",
            "startOffset": 24699,
            "title": "VVWR A27-Specific IFN-\u03b3 stimulation"
        },
        {
            "endOffset": 24149,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Plates were stained with crystal violet 1%.",
            "startOffset": 24106,
            "title": "Viral plaque assay"
        },
        {
            "endOffset": 26401,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "We asked if this profile was stable at longer time points post-vaccination (Fig. 3).",
            "startOffset": 26317,
            "title": "Measuring the cytokine profile"
        },
        {
            "endOffset": 30258,
            "parents": [],
            "secId": "s0095",
            "sentence": "Fundamental to the success in the development of an immune therapy against viral diseases, is to generate a vaccine that induces a robust immune response able to control virus replication.",
            "startOffset": 30070,
            "title": "Discussion"
        },
        {
            "endOffset": 35392,
            "parents": [],
            "secId": "s0095",
            "sentence": "However, having no information regarding the rate of change for these immune responses, additional studies beyond the scope of this work would be necessary to explain for such a behavior.",
            "startOffset": 35205,
            "title": "Discussion"
        },
        {
            "endOffset": 27286,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Fig. 4A shows that the production of total IgG was higher in animals immunized with pA27LOPT or pA27LOPT + I, compared to control groups.",
            "startOffset": 27149,
            "title": "Humoral immune response analysis"
        },
        {
            "endOffset": 18919,
            "parents": [],
            "secId": "s0005",
            "sentence": "Our data demonstrate that virus-free DNA vaccines represent a safe alternative to limit viral infections.",
            "startOffset": 18814,
            "title": "Introduction"
        },
        {
            "endOffset": 28577,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "As expected, VACV replicated to high titers in the lungs of na\u00efve mice.",
            "startOffset": 28506,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 19522,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A total of 4 mice per group were used in the immune response experiments.",
            "startOffset": 19449,
            "title": "Mice"
        },
        {
            "endOffset": 24105,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "The cells were incubated for 2 days at 37 \u00b0C with 5% CO2.",
            "startOffset": 24048,
            "title": "Viral plaque assay"
        },
        {
            "endOffset": 26753,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Thus, our vaccine formulation induced a TH1-biased immune response longitudinally.",
            "startOffset": 26671,
            "title": "Measuring the cytokine profile"
        },
        {
            "endOffset": 28505,
            "parents": [
                {
                    "id": "s0065",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Six days post-infection, mice organs were harvested, and viral titers were determined in the initial site of infection (lungs) and in distal organs (ovaries).",
            "startOffset": 28347,
            "title": "Measuring viral load after intranasal inoculation with VACV"
        },
        {
            "endOffset": 21683,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 21682,
                    "startOffset": 21678
                }
            },
            "secId": "s0035",
            "sentence": "Two weeks after the third immunization, the T cell-mediated immune response was measured by ELISPOT assay using the capture anti-mouse IFN-\u03b3 antibody (R&D Systems, Minneapolis, MN, USA) and High-Protein Binding IP 96-well Multiscreen TM plates (Millipore, Bedford, MA, USA) as previously described [23].",
            "startOffset": 21380,
            "title": "IFN-\u03b3 ELISPOT assay"
        },
        {
            "endOffset": 21027,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Spleens from mice were collected and macerated using the back of a syringe plunger.",
            "startOffset": 20944,
            "title": "Splenocytes preparation"
        },
        {
            "endOffset": 20160,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 20159,
                    "startOffset": 20155
                }
            },
            "secId": "s0020",
            "sentence": "The pA27L and pA27LOPT constructs containing an IgE leader sequence, and a hemagglutinin tag sequence were synthesized and cloned into the pVAX1 (Invitrogen, Grand Island, NY, USA) as previously described [23].",
            "startOffset": 19950,
            "title": "Vaccine design and plasmid purification"
        },
        {
            "endOffset": 30423,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 30422,
                    "startOffset": 30418
                }
            },
            "secId": "s0095",
            "sentence": "ACAM2000, the current smallpox vaccine, is a live virus vaccine, and is not safe for immunocompromised individuals or patients with a history of skin diseases [27].",
            "startOffset": 30259,
            "title": "Discussion"
        },
        {
            "endOffset": 16176,
            "parents": [],
            "secId": "s0005",
            "sentence": "The possible adverse events from this vaccine rises a common concern, if a vaccination campaign had to be resumed in case of a bioterror attack using this agent.",
            "startOffset": 16015,
            "title": "Introduction"
        },
        {
            "endOffset": 31702,
            "parents": [],
            "secId": "s0095",
            "sentence": "In this regard, several approaches have been implemented to develop an A27-coding DNA-based vaccine against smallpox.",
            "startOffset": 31585,
            "title": "Discussion"
        },
        {
            "endOffset": 24653,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0060",
            "sentence": "Data were evaluated for equality of variance with the Brown-Forsythe tests and were transformed with X = log(x) to normalize when necessary.",
            "startOffset": 24513,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 23336,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0050",
            "sentence": "The virus was kindly provided by Dr. Bernard Moss (NIAID, NIH), and propagated in Vero cells using DMEM supplemented with 2% FBS.",
            "startOffset": 23207,
            "title": "Intranasal challenge and virus titers in lung and ovaries"
        },
        {
            "endOffset": 24200,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0055",
            "sentence": "Plaques were counted and viral titters calculated.",
            "startOffset": 24150,
            "title": "Viral plaque assay"
        }
    ],
    "docId": "S0264410X17307612",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Osmarie",
                "initial": "O.",
                "last": "Mart\u00ednez"
            },
            {
                "email": null,
                "first": "Ariana",
                "initial": "A.",
                "last": "Bravo Cruz"
            },
            {
                "email": null,
                "first": "Saritza",
                "initial": "S.",
                "last": "Santos"
            },
            {
                "email": null,
                "first": "Maite",
                "initial": "M.",
                "last": "Ram\u00edrez"
            },
            {
                "email": null,
                "first": "Eric",
                "initial": "E.",
                "last": "Miranda"
            },
            {
                "email": null,
                "first": "Joanna",
                "initial": "J.",
                "last": "Shisler"
            },
            {
                "email": "miguel.otero2@upr.edu",
                "first": "Miguel",
                "initial": "M.",
                "last": "Otero"
            }
        ],
        "doi": "10.1016/j.vaccine.2017.05.091",
        "firstpage": "6007",
        "issn": "0264410X",
        "keywords": [
            "Adjuvant",
            "DNA vaccine",
            "Smallpox",
            "Vaccinia",
            "Virus-free"
        ],
        "lastpage": "6014",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge"
    }
}